Redx Pharma (REDX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

 7.50p
   
  • Change Today:
      0.000p
  • 52 Week High: 16.75
  • 52 Week Low: 4.00
  • Currency: UK Pounds
  • Shares Issued: 126.48m
  • Volume: 946
  • Market Cap: 9.49m
  • RiskGrade: 438

Redx Pharma Overview

Redx Pharma is in the pharma and biotech sector and is currently trading at 7.50p per share. In the last year Redx Pharma's share price has ranged from 4.00p to 16.75p.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -7882.9% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 73.5 n/a
Pr/Book 1.6  
Latest F'cast
Revenue -99.6% -100.0%
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Redx Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-14 n/a (4.26) (7.60)p n/a n/a n/a n/a 0.0%
30-Sep-15 n/a (8.82) (14.10)p n/a n/a n/a n/a 0.0%
30-Sep-16 n/a (15.41) (19.80)p n/a n/a n/a n/a 0.0%
30-Sep-17 30.47 1.65 1.40p 23.1 n/a n/a n/a 0.0%
30-Sep-18 0.13 (10.15) (7.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Redx Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
30-Sep-19 n/a (12.94) (6.89)p n/a n/a n/a n/a 0.0%
30-Sep-20 n/a (13.35) (5.89)p n/a n/a n/a n/a 0.0%

Copyright © 2019 FactSet Research Systems Inc. All rights reserved.

Redx Pharma Company Announcements

Directorate Update 14-Feb-2019 07:00 RNS
New in vivo data on ROCK2 12-Feb-2019 07:00 RNS
Receipt of Outstanding Loan 06-Feb-2019 11:25 RNS

Latest Redx Pharma Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Redx Pharma Market Data

Currency UK Pounds
Share Price 7.50p
Change Today 0.000p
% Change 0.00 %
52 Week High 16.75
52 Week Low 4.00
Volume 946
Shares Issued 126.48m
Market Cap 9.49m
RiskGrade 438

Redx Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
16.31% below the market average16.31% below the market average16.31% below the market average16.31% below the market average16.31% below the market average
17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average17.24% below the sector average
Price Trend
67.93% below the market average67.93% below the market average67.93% below the market average67.93% below the market average67.93% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Income Not Available
Growth
27.28% below the market average27.28% below the market average27.28% below the market average27.28% below the market average27.28% below the market average
47.37% below the sector average47.37% below the sector average47.37% below the sector average47.37% below the sector average47.37% below the sector average

Redx Pharma Dividends

No dividends found

Trades for 15-Feb-2019

Time Volume / Share Price
14:25 946 @ 7.40p

Redx Pharma Key Personnel

CFO James Mead

Top of Page